Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US1101221083
Ticker BMY
Company BRISTOL-MYERS SQUIBB
Currency $
Price
Aware Investor Index (AII) 3.4591
Recommendation BUY
P/E 27.60
ROE 20.19 %
Capitalization 78,739,700,000 $
Dividend Yield 3.35 %
P/S 3.49
AII Position 163
P/E Position 391
ROE Position 161
Capitalization Position 116
Dividend Yield Position 194
Sales 22,561,000,000 $
10-Year Average Earnings 2,852,600,000 $
Shares Outstanding 1,637,000,000
Equity 14,127,000,000 $
Dividend per Share 1.61 $
Industry Pharmaceutical
Country United States
BRISTOL-MYERS SQUIBB Investor Relations Web Site https://www.bms.com/investors.html







Sales:

YEAR MONTH AMOUNT
2018 12 22,561,000,000.00 $
2017 12 20,776,000,000.00 $
2016 12 19,427,000,000.00 $
2015 12 16,560,000,000.00 $
2014 12 15,879,000,000.00 $
2013 12 16,385,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 4,920,000,000.00 $
2017 12 1,007,000,000.00 $
2016 12 4,457,000,000.00 $
2015 12 1,565,000,000.00 $
2014 12 2,004,000,000.00 $
2013 12 2,563,000,000.00 $
2012 12 1,960,000,000.00 $
2011 12 3,709,000,000.00 $
2010 12 3,102,000,000.00 $
2009 12 3,239,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 14,127,000,000.00 $
2017 12 11,847,000,000.00 $
2016 12 16,347,000,000.00 $
2015 12 14,424,000,000.00 $
2014 12 14,983,000,000.00 $
2013 12 15,236,000,000.00 $
2012 12 13,638,000,000.00 $
2011 12 15,867,000,000.00 $
2010 12 15,638,000,000.00 $
2009 12 14,785,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 1,637,000,000
2017 12 1,652,000,000
2016 12 1,680,000,000
2015 12 1,679,000,000
2014 12 1,670,000,000
2013 12 1,662,000,000
2012 12 1,688,000,000
2011 12 1,717,000,000
2010 12 1,727,000,000
2009 12 1,978,000,000

 












Bloomberg News for BRISTOL-MYERS SQUIBB:



Google News for BRISTOL-MYERS SQUIBB:

GV Times - 7 hours ago
Do Most Analysts Favor Buy On Bristol-Myers Squibb Company ...
6 analysts out of 13 Wall Street brokerage firms rate Bristol-Myers Squibb Company (NYSE:BMY) as a Buy, while 0 see it as a Sell. The rest 7 ...
FinBulletin
Why Bristol-Myers Squibb (BMY) is a Top Dividend Stock for Your ...
Based in New York, Bristol-Myers Squibb (BMY) is in the Medical sector, and so far this year, shares have seen a price change of -8.71%.
Benzinga
Bristol-Myers Squibb Company (BMY) – it's time to buy. Check out ...
Regarding Bristol-Myers Squibb Company [BMY] currently, the latest Wall Street ratings we can see is from the fiscal quarter that's going to end ...
US Post News
Bristol-Myers (BMY) is an Incredible Growth Stock: 3 Reasons Why
Our proprietary system currently recommends Bristol-Myers Squibb (BMY) as one such stock. This company not only has a favorable Growth ...
Yahoo Finance - 9 May 2019
Why I Like Bristol-Myers Squibb Company (NYSE:BMY)
Bristol-Myers Squibb Company (NYSE:BMY) is a stock with outstanding fundamental characteristics. When we build an investment case, we ...
Seeking Alpha
Baupost's 13F shows new stakes in Bristol-Myers Squibb (BMY ...
Baupost's 13F shows new stakes in Bristol-Myers Squibb (BMY), Celgene (CELG), increase in eBay (EBAY), CBS (CBS) (more...).
Financial Mercury
Bristol-Myers Squibb Earnings: BMY Stock Pops on Q1 Beat
Bristol-Myers Squibb (NYSE:BMY) reported earnings per share of $1.10 for the first quarter of 2019. This is up from the company's earnings per ...
Hermann Herald
Bristol-Myers prices $19B debt offering
Bristol-Myers Squibb (NYSE:BMY) has priced a $19B offering of senior unsecured notes that will help fund its acquisition of Celgene ...
The Dwinnex - 5 days ago
Investors are poised to realize their wishes : Bristol-Myers Squibb ...
When looking at price performance, Bristol-Myers Squibb Company (NYSE:BMY) has experienced quite a remarkable year. This stock inclined ...
Find News
Can Bristol-Myers Squibb Company's (NYSE:BMY) ROE Continue ...
To keep the lesson grounded in practicality, we'll use ROE to better understand Bristol-Myers Squibb Company (NYSE:BMY). Over the last ...


Back